Dr. Srinivas Tantravahi is an Associate Professor specializing in Hematology and Hematologic Malignancies within the Division of Hematology at the Huntsman Cancer Institute, University of Utah. Board certified in Hematology and Medical Oncology, Dr. Tantravahi is an expert in the management of leukemias, myeloproliferative neoplasms, bone marrow failure, and genetic predisposition to related conditions.

After completing his Internal Medicine residency and Hematology and Oncology fellowship training at the University of Utah School of Medicine, Dr. Tantravahi joined the University of Utah faculty in 2015. He actively engages in pioneering clinical trials, investigating innovative therapeutic strategies for myeloproliferative neoplasms, chronic myeloid leukemia, acute myeloid leukemia, and acute lymphoblastic leukemia. Dr. Tantravahi is a member of American Society of Hematology, Society of Hematologic Oncology, and American Society of Clinical Oncology.

Dr. Tantravahi's clinical and research focus extends to the diagnosis and treatment of telomere biology disorders, with a particular emphasis on unraveling the genetic mechanisms underlying these disorders and various germline predispositions to bone marrow failure and leukemias.